Democratic presidential candidate Bernie Sanders is calling on a drug company to justify a dramatic spike in the price of a 62-year-old drug that was reported Sunday.
One day before rival Hillary Clinton is set to propose a plan to rein in high costs for specialty drugs, Sanders in a letter to Turing Pharmaceuticals demanded an explanation for why the price of a drug used to treat dangerous parasitical infections leapt from $13.50 per tablet to $750 after the company acquired the drug from a competitor.
The price hike followed the sale of the drug, Daraprim, to Turing in August for $55 million, the New York Times
reported.
“The enormous, overnight price increase for Daraprim is just the latest in a long list of skyrocketing price increases for certain critical medications,”
wrote Sanders and Rep. Elijah Cummings, who are investigating sudden jumps in the costs of older, generic medicines.
Read more:
Bernie Sanders questions drug price spike
That is a heck of a jump.